NCT00109148已完成2 期
A Study to Assess the Safety and Efficacy of MK0364 in Obese Patients
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 500
研究概览
简要总结
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are obese (considerably overweight) based on body mass index.
排除标准
- •Patients with serious or unstable current or past medical conditions
研究者
相似试验
已完成
1 期
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008)Cancer, AdvancedNCT00750178Merck Sharp & Dohme LLC30
尚未招募
2 期
KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary CarcinomaHER2-positive Colorectal CancerHER2-positive Biliary Tract CancerNCT05985707Peking University Cancer Hospital & Institute80
已完成
2 期
A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)OsteoarthritisNCT00296569Merck Sharp & Dohme LLC150
已完成
1 期
Clinical Study of KD6001 in Advanced Solid TumoursSolid TumorNCT05230290Shanghai Kanda Biotechnology Co., Ltd.13
撤回
3 期
Safety and Efficacy Study of an Etoricoxib and Tizanidine Fixed Dose Combination in Participants With Moderate to Severe Acute Low Back Pain (MK-0663B-164)Low Back PainNCT01979510Merck Sharp & Dohme LLC